C10010685 / invoice 10000
Species:CANINE
Breed:French Bulldog
Age (years):2
Diagnosis or signs:itchy skin
Consult notes
Animal clinical history (3 most recent)
2026-03-10T00:00:00Z 11:42 AM
HISTORY: Presented for vaccination and cytopoint. The owner enquired about Cytopoint injection for licking is currently licking his feet again. The owner recently changed parasite prevention from nexgard spectra to bravecto so needs a proheart injection Current meds: BravectoVaccination: Proheart SR-12, C4 and oral BB administered.Parasite Prevention: Recently switched from nexgard spectra to bravectoPre-existing conditions: noneAccess to toxins eg. Rodenticide: none EXAMINATION:Body Condition Score: 5/9Pain Scale (0-4): 0/4Hydration status (%): hydration clinically adequateCardiovascular: cardiac auscultation normal, normal rhythm, pulse pressures normal and synchronousRespiratory: thoracic auscultation clear sounds bilaterally, respiratory effort normal, no nasal dischargeNeurological: neurologically no significant findingsMusculoskeletal: ambulating normally, no palpable neck, spine, limb or joint painGastrointestinal:- Oral: normal, no mouth pain, dental score (1-4):not graded- Abdominal: no detectable pain on abdominal palpation- Rectal: not performedUrinary: NSFReproductive: NSFIntegument/Ears: there is erythema present between toes - due for cytopoitn so this should help with pruritisLymph Nodes: NSFEyes: NSFDemeanour/Behaviour: not discussed PROBLEM LIST:- Due for vaccination- Due for heartworm prevention DIFFERENTIAL DIAGNOSIS/ DIAGNOSIS:Not discussed. DIAGNOSTICS:None ASSESSMENT: Presented for a routine health check and vaccination. The examination revealed no significant abnormalities. Parasite prevention was discussed, and the recent change from nexgard spectra to bravectoTREATMENT: - Proheart SR-12 administered for heartworm prevention.C4 and oral BBCytopoint 20mg PLAN:- Continue with routine parasite prevention.- Re-evaluation as needed or for annual health check and vaccination.- Home into owner's care. CLIENT COMMUNICATION:Discussed the administration of the Proheart SR-12 vaccination. Confirmed that Cytopoint can be administered concurrently with vaccinations if required in the future for skin issues. Discussed the current parasite prevention protocol. No concerns were raised. Vital Signs Weight: 10;
Previous claim history (10)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2025-02-07 | C8299954 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2024-12-17 | C8085645 | HISTIOCYTOMA (CUTANEOUS, SKIN) |
| 2024-12-09 | C8048577 | HISTIOCYTOMA (CUTANEOUS, SKIN) |
| 2024-12-02 | C8018609 | PRURITUS - PRESENTING COMPLAINT |
| 2024-08-19 | C7599150 | DESEXING |
| 2024-07-19 | C7481890 | EAR INFECTION |
| 2024-07-04 | C7425692 | DERMATITIS - ATOPIC |
| 2024-04-03 | C7066875 | PYODERMA |
| 2024-03-19 | C7063914 | FLEA/TICK/WORM CONTROL |
| 2024-03-19 | C7063914 | Grooming |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation | 7.20 | 2026-03-10 | — |
| 20000 | tstarc_consultation | 12.40 | 2026-03-10 | — |
| 30000 | tstarc_consultation | 80.40 | 2026-03-10 | — |
| 40000 | tstarc_skin_medication_-_cytopoint | 179.20 | 2026-03-10 | — |
| 50000 | tstarc_vaccination_(canine) | 32.20 | 2026-03-10 | upstreamDSTP_routine_care_-_vaccinations_or_health_checks |
| 60000 | tstarc_vaccination_(canine) | 33.80 | 2026-03-10 | upstreamDSTP_routine_care_-_vaccinations_or_health_checks |
| 70000 | tstarc_heartworm_control | 123.20 | 2026-03-10 | upstreamDSTP_routine_care_-_heartworm_control |
UPM+
- DG02319HYPERSENSITIVITY (ALLERGIC) SKIN DISORDERDSTP_skin_-_allergic_disorder
Variant (sleepy_king)
HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.720
Threshold: 0.38
Above: ✓
Correct?